Views & Analysis Could the PPRS support a changing growth and innovation agen... Has the PPRS delivered on the aim to support the government’s growth and innovation agenda?
Oncology Servier’s ASCO 2025 Data: Advancing IDH-Mutated Cancer Treat... At ASCO 2025, Servier’s Becky Martin discusses IDH-mutated cancers, including key insights on Tibsovo & Voranigo, and the implications for patients.
